How do we make progress in phenotyping patients with LUT such as OAB and underactive detrusor, including using urine markers and microbiome data, in order to personalize therapy? ICI-RS 2023: Part 1.
Enrico Finazzi AgroEleonora RosatoAdrian WaggSanjay SinhaClaudia Fede SpicchialeMaurizio SeratiVito ManciniMathijs M de RijkTufan TarcanAlan WeinPaul AbramsGeorge Bou KheirPublished in: Neurourology and urodynamics (2024)
The article emphasizes the critical significance of adopting a comprehensive yet tailored approach to phenotyping patients with lower urinary tract symptoms, such as OAB and UAB. The intricate interplay between the lower urinary tract and various factors, metabolic, neurological, psychological, and gastrointestinal can define unique LUT profiles, enabling personalized therapies to replace the one-size-fits-all approach.